Facility-based constraints to exchange transfusions for neonatal hyperbilirubinemia in resource-limited settings

Cecilia A Mabogunje1, Sarah M Olaifa1, Bolajoko O Olusanya1

  • 1Cecilia A Mabogunje, Neonatal Unit, Massey Street Children's Hospital, Lagos, Nigeria.

Insights

Immediate exchange transfusion (ET) for severe neonatal hyperbilirubinemia is crucial but often delayed in low-resource settings. Addressing these delays is vital to prevent kernicterus and improve infant outcomes.

Area of Science:

  • Neonatal Medicine
  • Pediatric Hematology
  • Public Health in LMICs

Background:

  • Severe neonatal hyperbilirubinemia poses a risk of acute and chronic bilirubin encephalopathy.
  • Clinical guidelines recommend immediate exchange transfusion (ET) to prevent kernicterus.
  • Limited data exists on the interval between ET decision and initiation, particularly in low- and middle-income countries (LMICs).

Purpose of the Study:

  • To explore potential delays in initiating exchange transfusion (ET) for severe neonatal hyperbilirubinemia in LMICs.
  • To identify factors contributing to delays in ET procedures.
  • To emphasize the need for timely intervention to prevent kernicterus.

Main Methods:

  • Review of available evidence from LMICs concerning the ET process.
  • Analysis of stages and potential delays in ET initiation.
  • Examination of resource constraints and challenges in LMICs.

Main Results:

  • Delays in ET initiation are influenced by factors including intensive phototherapy, laboratory/logistical support, and clinical expertise.
  • Challenges in obtaining informed parental consent (religious objections) and financial burdens impede timely ET.
  • Secondary delays can occur due to post-treatment bilirubin rebound.

Conclusions:

  • Timely exchange transfusion (ET) is critical for managing severe neonatal hyperbilirubinemia and preventing kernicterus.
  • Resource limitations and socio-cultural factors in LMICs significantly contribute to ET delays.
  • Addressing these delays is essential to enhance the effectiveness of ET and reduce avoidable cases of kernicterus.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
368
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
441
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
315
Blood Transfusion and Agglutination02:45

Blood Transfusion and Agglutination

Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
15.5K
Blood Transfusion01:15

Blood Transfusion

Blood transfusion is a critical medical procedure that saves lives and treats various medical conditions. It involves transferring blood from a donor to a recipient. This process requires a thorough understanding of the ABO blood group system and its associated antigens and antibodies.
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
2.9K
Rh Blood Group01:19

Rh Blood Group

The Rhesus (Rh) antigen is crucial in determining blood groups and ensuring compatibility during blood transfusions.
4.1K